Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00844077 · ClinicalTrials.gov registry record
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 255
- Enrollment target
NCT00844077 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 255 participants.
The verdict
NCT00844077 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
Barrett's esophagus can progress to esophageal cancer, but it doesn't always. Current treatment is frequent surveillance via upper endoscopy with multiple biopsies to look for changes (dysplasia). Pathologists vary dramatically in their interpretation of Barrett's Metaplasia versus dysplasia and consensus is very difficult to achieve. The investigators propose a longitudinal study of subjects with confirmed Barrett's intestinal metaplasia without dysplasia to look for predictive factors for transformation to dysplasia or cancer. Potential biomarkers can be found in serum, plasma, urine, frozen or fixed Barrett's and Normal esophageal mucosa. In addition, the investigators are testing a brushing technique from CDx, Inc. for predictive factors. Subjects must have pathologically confirmed Barrett's intestinal metaplasia without history of dysplasia to be on this longitudinal study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2007-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00844077
The ClinicalTrials.gov registry entry for NCT00844077 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00844077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00844077 about?
NCT00844077 is a clinical study titled "Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus". Barrett's esophagus can progress to esophageal cancer, but it doesn't always. Current treatment is frequent surveillance via upper endoscopy with multiple biopsies to look for changes (dysplasia). Pathologists vary dramatically in their interpretation of Barrett's Metaplasia versus dysplasia and con...
What is the current status of trial NCT00844077?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2007-10.
Who is sponsoring clinical trial NCT00844077?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.